216 related articles for article (PubMed ID: 33952697)
1. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis.
Wang R; Godet I; Yang Y; Salman S; Lu H; Lyu Y; Zuo Q; Wang Y; Zhu Y; Chen C; He J; Gilkes DM; Semenza GL
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952697
[TBL] [Abstract][Full Text] [Related]
2. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.
Wang T; Gilkes DM; Takano N; Xiang L; Luo W; Bishop CJ; Chaturvedi P; Green JJ; Semenza GL
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3234-42. PubMed ID: 24938788
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J
J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.
El Guerrab A; Zegrour R; Nemlin CC; Vigier F; Cayre A; Penault-Llorca F; Rossignol F; Bignon YJ
PLoS One; 2011; 6(9):e25080. PubMed ID: 21966417
[TBL] [Abstract][Full Text] [Related]
7. Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.
Díaz B; Yuen A; Iizuka S; Higashiyama S; Courtneidge SA
J Cell Biol; 2013 Apr; 201(2):279-92. PubMed ID: 23589494
[TBL] [Abstract][Full Text] [Related]
8. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
9. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.
Chaturvedi P; Gilkes DM; Takano N; Semenza GL
Proc Natl Acad Sci U S A; 2014 May; 111(20):E2120-9. PubMed ID: 24799675
[TBL] [Abstract][Full Text] [Related]
11. Role of hypoxia-related proteins in invasion of ameloblastoma cells: crosstalk between NOTCH1, hypoxia-inducible factor 1α, a disintegrin and metalloproteinase 12, and heparin-binding epidermal growth factor.
da Costa NM; Fialho AD; Proietti CC; da Silva Kataoka MS; Jaeger RG; de Alves-Júnior SM; de Jesus Viana Pinheiro J
Histopathology; 2016 Jul; 69(1):99-106. PubMed ID: 26707922
[TBL] [Abstract][Full Text] [Related]
12. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
[TBL] [Abstract][Full Text] [Related]
14. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J
PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166
[TBL] [Abstract][Full Text] [Related]
15. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
16. Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis.
Zuo Q; Yang Y; Lyu Y; Yang C; Chen C; Salman S; Huang TY; Wicks EE; Jackson W; Datan E; Qin W; Semenza GL
Cell Rep; 2023 Mar; 42(3):112164. PubMed ID: 36857181
[TBL] [Abstract][Full Text] [Related]
17. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.
Chaturvedi P; Gilkes DM; Wong CC; ; Luo W; Zhang H; Wei H; Takano N; Schito L; Levchenko A; Semenza GL
J Clin Invest; 2013 Jan; 123(1):189-205. PubMed ID: 23318994
[TBL] [Abstract][Full Text] [Related]
20. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
